Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment

The Research Committee of the British Thoracic Society

Source: Eur Respir J 2003; 21: 478-482
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
The Research Committee of the British Thoracic Society. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment. Eur Respir J 2003; 21: 478-482

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
Source: Eur Respir J 2009; 33: 148-152
Year: 2009



Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004

Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005



The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study
Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019
Year: 2020



Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011


Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy following the guidelines for treatment
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001

The effect of combined chemotherapy according to the guidelines on the treatment for Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease
Source: Eur Respir J, 54 (1) 1900118; 10.1183/13993003.00118-2019
Year: 2019



Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018
Year: 2019



Pulmonary tuberculosis
Source: Respipedia Article
Year: 2018